Enosemi is a startup. Brouky records 1 investor associated with the company.
Develops AI-enabled breath-based diagnostics that detect disease by analyzing volatile organic compounds (VOCs) in exhaled breath, providing non-invasive, real-time detection capabilities.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.